Introduction {#S1}
============

To thrive and survive in complex environmental conditions, bacteria employ versatile signal transduction pathways to rapidly adapt to alterations in their surroundings. One of these pathways is the GacS/GacA two-component system, which detects and responds coordinately to external and internal stimuli, including different physiological state ([@B24]), metabolic levels ([@B7]), and pH ([@B40]), and translates them into appropriate adaptive responses.

The GacS/GacA system is a conserved global regulatory system in many Gram-negative bacteria, which is comprised of the hybrid sensor kinase GacS and the cognate response regulator GacA. In the presence of an as-yet-unidentified environmental signal, the GacS sensor kinase autophosphorylates and then activates the cognate GacA response regulator via phosphotransfer ([@B17]). In *Pseudomonas aeruginosa* and *Legionella pneumophila*, the activated GacA exclusively regulates the expression of several small non-coding RNAs (sRNAs) RsmY and RsmZ ([@B3]; [@B46]). Mutation of all these sRNAs in many bacteria resulted in the same phenotypes as mutants of the GacS/GacA system ([@B24]; [@B3]). GacA-activated sRNAs all have multiple GGA motifs for competitive binding to carbon storage regulator (CsrA)/regulator of secondary metabolites (RsmA) family proteins ([@B57]). In addition, the CsrA/RsmA family proteins mediate either a negative or positive posttranscriptional effect by altering the rate of translation initiation or mRNA decay ([@B29]). A common consensus sequence (CANGGAYG) within the loop portion of a stem--loop structure in the 5′-untranslated region (UTR) is essential for RsmA/CsrA family proteins to bind target mRNAs ([@B26]). Two histidine kinases, LadS and RetS, are involved in modulating the function of the GacS/GacA system. In *P. aeruginosa* PAK, RetS affects the phosphorylation state of GacS ([@B16]). Crystallographic studies further indicated that RetS used the reversible unfolding of a helix, or helix cracking, to control interactions with GacS ([@B36]). In contrast to RetS, LadS in *P. aeruginosa* activates the function of GacA under high calcium conditions ([@B4]).

Extensive studies have demonstrated that the GacS/GacA system and its homologs play an important role in coordinating the expression of virulence factors required for successful infection of many plant- and animal-pathogenic bacteria ([@B19]). In *P. syringae* pv. *tomato* (*Pto*) DC3000 (hereafter termed *Pto* DC3000), GacA acts as master regulator to control carbon metabolism, motility, and production of virulence factors, syringomycin, and quorum-sensing (QS) signals ([@B6]). Furthermore, GacA positively regulates the transcription of the *pel*, *peh*, and *celV* genes that are responsible for the production of pectate lyases, pectinases, and cellulases in *Pectobacterium carotovorum* subsp. *carotovorum* (*Pcc*), and mutation of *gacA* results in an avirulent phenotype ([@B10]). Production of these exoenzymes was under the control of ExpI-ExpR QS system ([@B44]) and the QS system was positively regulated by the GacS/GacA system ([@B58]). The opportunistic pathogen *P. aeruginosa* caused extensive tissue damage on *Arabidopsis* and lettuce when infiltrated at high cell densities, while the *gacA* mutant sharply reduced the disease symptoms ([@B41]). Moreover, the *gacA* or *gacS* mutants of *P. aeruginosa* are also much less virulent in several animal models compared with their wild-type ([@B43]). In addition, the GacA homologs in human pathogens *Salmonella enterica* serovar *Typhimurium* and *Vibrio cholerae* act as key regulators of colonization, toxin production, and intracellular multiplication ([@B59]; [@B1]).

Hence, the GacS/GacA system represents a promising target for anti-infection drug development. Although the signaling circuit is well defined, little is known about the environmental signals that turn on the Gac/Rsm regulatory cascades. Short-chain fatty acids have been shown to induce the homologous systems in *Escherichia coli* and *Salmonella typhimurium* ([@B31]; [@B15]). Bacterial culture supernatants and lysed kin cells could act as signals that are sensed by the GacS/GacA--CsrA/RsmA pathway in *P. aeruginosa* ([@B24]; [@B32]). In addition, plant phenolic derivatives and the antibiotic azithromycin impaired the production of virulence factors in *P. aeruginosa* via the GacS/GacA system ([@B42]; [@B61]).

In the present study, a *Pto* DC3000 (p970Gm-gacSDC3000p) transcriptional fusion reporter was developed to screen inhibitors of the GacS/GacA system from secondary metabolites produced by rhizobacteria. The extract of *Bacillus* sp. BR3 significantly repressed *gacS* expression and reduced the GacS protein level, and impaired GacA-dependent expression of small RNAs, motility, and the hypersensitive response (HR) triggered by *Pto* DC3000. These results contributed to our understanding of interspecies cell-to-cell communication in bacteria, and provided an additional method by which rhizobacteria might attenuate virulence factor production by plant and animal pathogenic bacteria.

Materials and Methods {#S2}
=====================

Bacterial Strains, Plasmids, and Growth Conditions {#S2.SS1}
--------------------------------------------------

The bacterial strains and plasmids used in this study are listed in [Table 1](#T1){ref-type="table"}. *E. coli* was routinely grown in Luria-Bertani (LB) medium at 37°C. *Pseudomonas syringae* pv. *tomato* DC3000, *P. carotovorum* subsp. *carotovorum* (*Pcc*) Z3-3, *Pseudomonas fluorescens* 2P24, and *Agrobacterium tumefaciens* NTL4 (pZLR4) were cultured in LB medium, King's Broth (KB) ([@B25]), or minimal medium ABM ([@B8]) at 28°C. Type three secretion system (TTSS)-inducing minimal medium was used for immunoblotting analysis of AvrPto protein ([@B22]). When necessary, growth media were supplemented with ampicillin (Ap) (50 μg ml^--1^), kanamycin (Km) (50 μg ml^--1^), gentamycin (Gm) (5 μg ml^--1^), tetracycline (Tet) (20 μg ml^--1^), or 5-bromo-4-chloro-3-indolyl-β-[D]{.smallcaps}-galactopyranoside (X-gal) (40 μg ml^--1^).

###### 

Bacterial strains, plasmids, and primers used in this study.

  **Strains or plasmids**                                    **Relevant characteristics**                                                             **References or source**
  ---------------------------------------------------------- ---------------------------------------------------------------------------------------- --------------------------
  **Strains**                                                                                                                                         
   *Pseudomonas syringae*                                                                                                                             
    DC3000                                                   Wild-type                                                                                [@B6]
    DC3000*gacA*                                             GacA~DC3000~-derivative of DC3000, Km^r^                                                 [@B6]
    DC3000*hrcQ-U*                                           DC3000 Δ*hrcQ-U*:ΩSp^r^/Sm^r^                                                            [@B27]
    DC3000-GacSVSV                                           DC3000 with a VSV-G epitope sequence tagged to the C terminus of GacS                    This work
   *Pseudomonas fluorescens*                                                                                                                          
    2P24                                                     Wild-type                                                                                [@B62]
    2P24**△***gacA*                                          Derivative of 2P24, *gacA* gene in-frame deletion, Ap^r^                                 [@B62]
    2P24**△***retS*                                          Derivative of 2P24, *retS* gene in-frame deletion, Ap^r^                                 [@B35]
    *Pectobacterium carotovorum* subsp. *carotovorum* Z3-3   Wild-type                                                                                Laboratory
    *Agrobacterium tumefaciens* NTL4(pZLR4)                  *A. tumefaciens* NT1 derivative carrying a *traG--lacZ* reporter fusion, AHL biosensor   [@B8]
  **Plasmids**                                                                                                                                        
   p970Gm-rsmYDC3000p                                        Derivative of DC3000, *rsmY--lacZ* transcriptional fusion, Gm^r^                         This work
   p970Gm-rsmZDC3000p                                        Derivative of DC3000, *rsmZ--lacZ* transcriptional fusion, Gm^r^                         This work
   p970Gm-gacSDC3000p                                        Derivative of DC3000, *gacS--lacZ* transcriptional fusion, Gm^r^                         This work
   p970Gm-rsmYp                                              Derivative of 2P24, *rsmY--lacZ* transcriptional fusion, Gm^r^                           [@B60]
   pME6013-2P24proC                                          Derivative of 2P24, *proC--lacZ* translational fusion, Tet^r^                            This work
   pME6013-phlA                                              Derivative of 2P24, *phlA--lacZ* translational fusion, Tet^r^                            [@B63]
   p2P24Km                                                   Suicide plasmid with *sacB* used for homologous recombination, Km^r^                     [@B63]
   p2P24Km-gacSVSV                                           p2P24Km with a VSV-G epitope sequence tagged to the C terminus of GacS, Km^r^            This work
   pME6032                                                   *lacI*--P*tac* expression vector, Tet^r^                                                 [@B18]
   pME-gacS                                                  pME6032 with *gacS* under P*tac* control                                                 This work
   Primers                                                   Sequence (5′→ 3′)                                                                        Restriction site
   rsmZp1DC3000                                              AT[GGATCC]{.ul} AGTAAACCTCCCACCG                                                         *Bam*HI
   rsmZp2DC3000                                              AT[GGATCC]{.ul} GCTTCGATAGTAGAGATTTAAC                                                   *Bam*HI
   RsmYBglII5p                                               ATG[AGATCT]{.ul} TTTATGCGAGCAAGCTG                                                       *Bgl*II
   RsmYBglII3P                                               ATG[AGATCT]{.ul} TTCACCCCGCCGTCCTGGC                                                     *Bgl*II
   gacS-promoterF                                            GC[GGATCC]{.ul} TCCGTTTTAGTAGTGTGCTC                                                     *Bam*HI
   gacS-promoterR                                            AT[GGATCC]{.ul} GGCACAGGGTCAGCAACAGCAC                                                   *Bam*HI
   gacS-vsv2R                                                TTTTCCTAATCTATTCATTTCAATATCTGTATACACACTTGTCTCCTGCATCCAG                                  
   gacS-vsv3F                                                TATACAGATATTGAAATGAATAGATTAGGAAAACTCAAGAAACTGGGAATCAAAG                                  
   gacS-vsv4R                                                AT[GGATCC]{.ul} TGGCTGCCCAGCGGTGGCAG                                                     *Bam*HI
   proC-F-6013                                               AT[GAATTC]{.ul} TTGCACAGCGCCTGTCCGAGCAAC                                                 *Eco*RI
   proC-R-6013                                               CTTGG[CTGCAG]{.ul} AATACGCGTGTTGCTCATGACAGGTCCT                                          *Pst*I
   gacS-*Xho*I                                               ATA[CTCGAG]{.ul} CTCAGCCTCGATCGTTTCCTGGGGC                                               *Xho*I
   gacS-*Eco*RI                                              AT[GAATTC]{.ul} AGAGTAATGTGCCCACACTGAC                                                   *Eco*RI
   63F                                                       CAGGCCTAACACATGCAAGTC                                                                    
   1387R                                                     GGGCGGTGATGTACAAGGC                                                                      

Ap, ampicillin; Gm, gentamicin; Km, kanamycin; Tet, tetracycline.

DNA Manipulation and PCR Amplification of 16S rRNA Gene {#S2.SS2}
-------------------------------------------------------

Chromosomal DNA from strains *Pto* DC3000 and *Bacillus* sp. BR3, plasmid DNA extraction, and other molecular assays were performed according to standard procedures ([@B49]). Electroporation of *Pto* DC3000 and *P. fluorescens* cells with plasmid DNA was performed as described previously ([@B9]). The oligonucleotides used are listed in [Table 1](#T1){ref-type="table"}.

To ascertain its taxonomic position, the genomic DNA of strain BR3 was used as a templet for PCR amplification using primers 63F and 1387R ([@B37]). The PCR product was sequenced by the Sanger method at Sangon Biotech Co., Ltd., Shanghai, China. The obtained sequences were compared with sequences deposited in GenBank using a BLASTN algorithm ([@B2]).

Construction of the Transcriptional *lacZ* Fusions and the Overexpression Plasmid {#S2.SS3}
---------------------------------------------------------------------------------

To construct the reporter strain *Pto* DC3000 (p970Gm-gacSDC3000p), the *gacS* promoter region from *Pto* DC3000 was PCR amplified using the primers gacS-promoterF/gacS-promoterR. The amplicon was then inserted into the *Bam*HI site of plasmid pRG970Gm to create the *gacS*--*lacZ* transcriptional fusion plasmid p970Gm-gacSDC3000p, which was introduced into *Pto* DC3000 via electroporation ([@B52]). In the same way, the promoter regions of *rsmY* and *rsmZ* from *Pto* DC3000 were amplified by PCR using primer pairs RsmYBglII5p/RsmYBglII3p and rsmZp1DC3000/rsmZp2DC3000, respectively. The products were then cloned into plasmid pRG970Gm to obtain p970Gm-rsmYDC3000p and p970Gm-rsmZDC3000p. These plasmids were then introduced into appropriate *Pto* strains by electroporation.

Plasmid pME-gacS expressing the *gacS* gene under the control of the isopropyl β-[D]{.smallcaps}-thiogalactoside (IPTG)-inducible *tac* promoter (P*tac*) was constructed as follows. The *gacS* gene was amplified by PCR with the primers gacS-*Xho*I/gacS-*Eco*RI and cloned into pME6032, yielding pME-gacS. When required, 0.25 and 0.5 mM of IPTG were added to induce the P*tac* promoter of the plasmid pME6032, respectively.

Preparation and Screening of Extracts From Soil Bacteria {#S2.SS4}
--------------------------------------------------------

Soil samples were collected from various regions in Guangxi, China, and rhizobacteria were isolated using LB plates. The isolates were cultured in 5 ml of seed broth at 28°C for 7 days ([@B34]). One milliliter of the cultures was extracted using an equal volume of ethyl acetate. The ethyl acetate extracts were evaporated and dissolved in 200 μl of 100% dimethyl sulfoxide (DMSO). A portion (5 μl) of the extract was mixed with 1 ml of bacterial suspension of the reporter strain *Pto* DC3000 (p970Gm-gacSDC3000p). After 7 h of incubation at 28°C, the β-galactosidase activity was assayed using the [@B38] method.

Swarming Assay and Hypersensitive Response Test {#S2.SS5}
-----------------------------------------------

*Pto* DC3000 and its *gacA* mutant were cultured overnight in KB liquid medium. Then, 5 μl of the stationary phase cultures was spotted onto SWM agar medium (0.4% agar) with BR3 extract (at final a concentration of 16 or 32 μg ml^--1^). The plates were incubated overnight at 28°C and then imaged ([@B6]).

The procedures for HR testing in tobacco leaves were previously published ([@B11]). Young, fully expanded third and fourth leaves from approximately 8-week-old *Nicotiana tabacum* L. cv. Samsun were used for the HR test. Bacterial cells \[1 × 10^7^ colony forming units (CFU) ml^--1^\] in the absence or presence of the BR3 extract were infiltrated into tobacco leaves as indicated in the figure captions. Images were acquired at 20 h after infiltration. DMSO was infiltrated as a control.

Mutant Strain Construction and Western Blotting Analysis {#S2.SS6}
--------------------------------------------------------

To construct a C-terminal vesicular stomatitis virus glycoprotein (VSV-G) epitope-GacS fusion, a PCR-generated fragment with the sequence 5′-TATACAGATATTGAAATGAATAGATTAG-3′ was inserted in-frame before the stop codon of *gacS* and cloned into p2P24Km ([@B63]). The resulting plasmid was introduced into strain *Pto* DC3000 by electroporation, and the wild-type copy was replaced by the modified version after two recombination events under high-sucrose stress. Substitution was confirmed by sequencing.

To analyze the effect of the BR3 extract on the protein levels of GacS and the TTSS effector AvrPto, *Pto* DC3000 and its derivatives were cultured in TTSS-inducing minimal medium at 20°C for 16 h. Cell lysates were prepared by sonication and resuspended in SDS sample buffer. The samples were separated by SDS--PAGE and protein levels were analyzed using western blotting with anti-VSV antibodies (Sangon Biotech) or anti-AvrPto antibodies ([@B13]).

Extraction and Detection of 2,4-Diacetylphloroglucinol and *N*-Acyl Homoserine Lactone {#S2.SS7}
--------------------------------------------------------------------------------------

*Pseudomonas fluorescens* 2P24 and its derivative strains were cultured in 20 ml of KBG (KB broth supplemented with 2% glucose) as described above. The antibiotic 2,4-Diacetylphloroglucinol (DAPG) was extracted from the culture supernatant and assayed using a previously described HPLC method ([@B51]).

Cultures of *P. carotovorum* subsp. *carotovorum* (*Pcc*) Z3-3 were grown overnight in LB medium with DMSO or the extract of strain BR3. One milliliter of the cultures was extracted with an equal volume of ethyl acetate. The ethyl acetate extracts were dried and resuspended in 50 μl of methanol. A portion (200 μl) of *A. tumefaciens* NTL4 (pZLR4) (OD~600~ = 0.8) with 5 μl of the extract solution was incubated at 28°C for 3 h, and then β-galactosidase activities were quantified ([@B38]).

Assessing the Inhibition of Pathogenicity of *Pto* DC3000 in *Arabidopsis* and Z3-3 in Chinese Cabbage by the BR3 Extract {#S2.SS8}
-------------------------------------------------------------------------------------------------------------------------

*Arabidopsis* plants were grown in a growth room at 23°C and 70% relative humidity under a 14-h light cycle. Strain *Pto* DC3000 was grown on KB agar overnight at 28°C and resuspended in water with the extract from strain BR3 or DMSO at 10^5^ CFU μl^--1^, 20 μl of the suspension was infiltrated into 4-week-old *Arabidopsis* leaves. Bacterial populations were determined at day 0 and day 3. Three 1-cm-diameter leaf disks were collected from three independent plants, and ground in 1 ml of 10 mM MgCl~2~. Bacterial colonies were then counted 2 days after plating 10 μl from serial dilutions on KB plates. For the pathogenicity test in Chinese cabbage, *Pcc* Z3-3 was grown in LB broth at 28°C for 12 h. Cells were harvested and resuspended in phosphate-buffered saline (PBS) to 10^8^ CFU ml^--1^ with or without the BR3 extract. For each Chinese cabbage leaf, three wounds were punched and inoculated with 10 μl of bacterial suspension. Maceration symptoms were documented at 30 h post-inoculation, as described previously ([@B33]).

Statistical Analysis {#S2.SS9}
--------------------

All experiments were performed in triplicate. The data were analyzed and compared by performing two-sample independent *t*-tests using DPS v9.50^[1](#footnote1){ref-type="fn"}^.

Results {#S3}
=======

The Extract of Strain BR3 Reduced the Expression of *gacS* in *Pto* DC3000 {#S3.SS1}
--------------------------------------------------------------------------

Extracts from 5000 isolates obtained from soil were tested for their abilities to suppress the β-galactosidase activity of the *gacS*--*lacZ* transcriptional fusion in the strain *Pto* DC3000 that carrying reporter plasmid p970Gm-gacSDC3000p. The extract from a strain named BR3 showed significant inhibitory activity ([Figure 1A](#F1){ref-type="fig"}). Analysis of the 16S rRNA gene sequence of BR3 indicated that this organism belongs to *Bacillus* sp. (data not shown). Introduction of pME-gacS into the wild-type DC3000 improved the promoter activities of the *gacS* gene ([Figure 1A](#F1){ref-type="fig"}). However, the promoter activities of *gacS* were considerably induced in the extract-treated wild-type DC3000 with plasmid pME-gacS, indicating that the expression of *gacS* gene was repressed by the BR3 extract ([Figure 1A](#F1){ref-type="fig"}). To further verify the effect of the BR3 extract on the expression of the *gacS* gene, the level of GacS protein was determined. Western blot analysis of the chromosomal *gacS*-*vsv* fusion strain showed that GacS protein production was significantly decreased in cells treated with the BR3 extract ([Figure 1B](#F1){ref-type="fig"}). Our data also showed that the BR3 extract had no effect on the growth of *Pto* DC3000 ([Figure 1C](#F1){ref-type="fig"} and [Supplementary Figure S1](#FS1){ref-type="supplementary-material"}). Taken together, these results suggested that the BR3 extract suppressed the expression of *gacS* gene.

![An extract of strain BR3 inhibits the expression of *gacS* and the GacS protein levels. **(A)** β-Galactosidase activities of the reporter fusion *gacS*--*lacZ* in *Pto* DC3000 (pME6032) and *Pto* DC3000 (pME-gacS) with DMSO or the BR3 extract (32 μg ml^--1^) were measured at 14 h after inoculation into KB medium. Different concentration of IPTG was added to induce the P*tac* promoter of the pME6032 as indicated. The experiments were performed in triplicate; average values ± standard deviations are shown. ^∗^*P* \< 0.05 and ^∗∗^*P* \< 0.01. **(B)** Western blotting analysis of GacS-VSV in the absence or presence of the BR3 extract. An antibody directed against β subunit of RNA polymerase (RNAP) was used as a loading control in this and later blots. There independent experiments were performed; a representative blot is shown. **(C)** The extract of strain BR3 (32 μg ml^--1^) did not influence the growth of *Pto* DC3000. The experiments were performed in triplicate; average values ± standard deviations are shown.](fmicb-10-02005-g001){#F1}

The BR3 Extract Inhibited GacA- Dependent sRNA Expression in *Pto* DC3000 {#S3.SS2}
-------------------------------------------------------------------------

RsmZ-like non-coding sRNAs are regulated by the GacS/GacA system ([@B24]; [@B39]); therefore, the expression of the *rsmZ* and *rsmY* genes was further analyzed in the presence or absence of the BR3 extract. The β-galactosidase activities of the *rsmZ*--*lacZ* fusion or the *rsmY*--*lacZ* fusion in wild-type *Pto* DC3000 were significantly higher than those in *gacA* mutants, suggesting that GacA positively regulated the *rsmY* and *rsmZ* genes expression ([Figure 2](#F2){ref-type="fig"}). Addition of the BR3 extract (16 μg ml^--1^) reduced the expression of the *rsmZ*--*lacZ* and *rsmY*--*lacZ* fusions in the wild-type *Pto* DC3000 compared with that in the DMSO-treated control ([Figure 2](#F2){ref-type="fig"}). Interestingly, the BR3 extract had no effect on the expression of *rsmZ*--*lacZ* and *rsmY*--*lacZ* fusions in the *gacA* mutant ([Figure 2](#F2){ref-type="fig"}). These data indicated that the BR3 extract affected the expression of *rsmZ* and *rsmY* via the GacS/GacA system.

![Regulation of *rsmZ* **(A)** and *rsmY* **(B)** expression in the presence or absence of the BR3 extract. β-Galactosidase activities of the reporter fusions *rsmZ*--*lacZ* **(A)** or *rsmY*--*lacZ* **(B)** in *Pto* strains with DMSO or the BR3 extract (16 μg ml^--1^) were measured at various time points tested after inoculation into KB medium. Growth is indicated by the dotted line. The experiments were performed in triplicate; average values ± standard deviations are indicated.](fmicb-10-02005-g002){#F2}

The Effect of the BR3 Extract on Bacterial Swarming Motility, Effector AvrPto Production, and HR on Tobacco {#S3.SS3}
-----------------------------------------------------------------------------------------------------------

Previous studies indicated that the swarming motility of the *gacA* mutant was much reduced compared with that of wild-type *Pto* DC3000 ([@B6]). Therefore, we checked whether the BR3 extract influenced the swarming motility of *Pto* DC3000. As expected, when treated with the extract, the wild-type displayed a swarming deficiency resembling that of its *gacA* mutant. While the swarming motility of the *gacA* mutant was not further effected upon the treatment of the BR3 extract ([Figure 3A](#F3){ref-type="fig"}).

![Influence of the BR3 extract on swarming motility, AvrPto production, and HR. **(A)** Swarming ability was tested on semisolid medium after 12 h of incubation at 28°C for *Pto* DC3000 in the absence or presence of the BR3 extract. Statistical significance was calculated using *t*-tests, ^∗^*P* \< 0.05 and ^∗∗^*P* \< 0.01. **(B)** Immunoblotting analysis with anti-AvrPto antibodies of strain *Pto* DC3000 in the absence or presence of the BR3 extract. **(C)** Effect of the BR3 extract on the elicitation of the hypersensitive response by *Pto* DC3000 in tobacco leaves. (1) DC3000 with 0 μl of DMSO; (2) DC3000 with 0 μl of the BR3 extract; (3) DC3000 with 5 μl of DMSO; (4) DC3000 with 5 μl of the BR3 extract (16 μg ml^--1^); (5) DC3000 with 10 μl of DMSO; (6) DC3000 with 10 μl of the BR3 extract (16 μg ml^--1^); (7) the *hrcQ-U* mutant with 0 μl of DMSO; (8) the *hrcQ-U* mutant with 0 μl of the BR3 extract; (9) the *hrcQ-U* mutant with 5 μl of DMSO; (10) the *hrcQ-U* mutant with 5 μl of the BR3 extract (16 μg ml^--1^); (11) the *hrcQ-U* mutant with 10 μl of DMSO; (12) the *hrcQ-U* mutant with 10 μl of the BR3 extract (16 μg ml^--1^); (13) 10 μl of DMSO; and (14) 10 μl of the BR3 extract (16 μg ml^--1^).](fmicb-10-02005-g003){#F3}

GacA regulates the expression of *hrpL* a master regulator of TTSS ([@B6]); therefore, we further analyzed the protein level of the TTSS effector AvrPto using western blotting and observed a significant reduction in the level AvrPto in the extract-treated wild-type ([Figure 3B](#F3){ref-type="fig"}). *Pto* DC3000 could elicit a typical HR in tobacco leaves when infiltrated at 1 × 10^7^ CFU ml^--1^ of bacterial cells, whereas the BR3 extract-treated *Pto* DC3000 failed to trigger HR at the same cell concentration ([Figure 3C](#F3){ref-type="fig"}). In addition, the *hrcQ-U* mutant was also incapable of showing HR with or without the BR3 extract ([Figure 3C](#F3){ref-type="fig"}). *Pto* DC3000-triggered HR on tobacco leaves is TTSS-dependent, these data suggested that the BR3 extract possible impaired the function of the TTSS in *Pto* DC3000.

The BR3 Extract Influences *rsmY~2P24~* and *phlA* Expression in *P. fluorescens* 2P24 {#S3.SS4}
--------------------------------------------------------------------------------------

The GacS/Rsm system is conserved in many Gram-negative bacteria, and globally regulates the production of a large number of secondary metabolites, including antibiotic 2,4-DAPG in *Pseudomonas* spp. ([@B30]). We measured the influence of the BR3 extract on the expression of the sRNA gene *rsmY~2P24~* and 2,4-DAPG biosynthetic gene *phlA* in *P. fluorescens* 2P24. The results showed that the BR3 extract reduced *rsmY~2P24~* transcription and strongly inhibited the expression of the *phlA*--*lacZ* translational fusion ([Figure 4](#F4){ref-type="fig"}). 2,4-DAPG production in the extract-treated cells reduced by approximately twofold ([Figure 4C](#F4){ref-type="fig"}). In addition, the expression of *rsmY~2P24~* and *phlA* was significantly decreased in the *gacA~2P24~* mutant, but no further decrease was found when treated with the BR3 extract ([Figures 4A,B](#F4){ref-type="fig"}). The expression of a housekeeping gene *proC*, which encodes the constitutive delta 1-pyrroline 5-carboxylate reductase (the third enzyme of proline biosynthesis), was not affected by the addition of the BR3 extract ([Figure 4D](#F4){ref-type="fig"}; [@B50]). In conclusion, our data suggested that the BR3 extract strongly inhibited the genes of the GacS/GacA regulon in *P. fluorescens* 2P24, and this inhibitory effect is GacA-dependent.

![Regulation of *rsmY*, *phlA*, and *proC* of strain 2P24 in the presence or absence of the BR3 extract. The β-galactosidase activities of transcriptional *rsmY*--*lacZ* **(A)**, translational *phlA*--*lacZ* **(B)**, and *proC*--*lacZ* **(D)** fusions were determined in *P. fluorescens* 2P24 in the absence or presence of the BR3 extract. Biosynthesis of 2,4-DAPG of strain 2P24 in the absence or presence of the BR3 extract was assayed by HPLC **(C)**. All experiments were performed in triplicate, and the mean values ± standard deviations are indicated, ^∗^*P* \< 0.05.](fmicb-10-02005-g004){#F4}

Effect of the BR3 Extract on the Virulence of *Pto* DC3000 and *Pectobacterium carotovorum* subsp. *carotovorum* Z3-3 {#S3.SS5}
---------------------------------------------------------------------------------------------------------------------

In phytopathogenic bacteria, the Gac/Rsm system is associated with pathogenicity. The observation that the BR3 extract suppressed the activity of the Gac/Rsm system prompted us to determine whether it interfered with the GacS/GacA system-dependent virulence process. As predicted, the extract-treated *Pto* DC3000 displayed a significantly reduced *in planta* population compared with that of the *Pto* DC3000 strain treated with DMSO ([Figure 5A](#F5){ref-type="fig"}).

![Effect of the extract of strain BR3 on the virulence function of *Pto* DC3000 and *Pcc* Z3-3. **(A)** Strain DC3000 in the absence or presence of the extract (16 μg ml^--1^) from strain BR3 was infiltrated into *Arabidopsis* leaves, and bacterial growth was determined. **(B)** Regulation by the BR3 extract on the production of AHL in *Pcc* Z3-3. The β-galactosidase activities of the *traG*--*lacZ* fusion in *A. tumefaciens* NTL4 (pZLR4) were measured via AHL signals that were extracted from strain Z3-3 in the absence or presence of the extract from strain BR3. **(C)** Disease lesions on Chinese cabbage caused by strain Z3-3 in the absence or presence of the BR3 extract. All experiments were performed in triplicate, and the mean values ± standard deviations are indicated, ^∗^*P* \< 0.05.](fmicb-10-02005-g005){#F5}

Previous data indicated that the GacS/GacA system positively regulates the ExpI/ExpR QS system, which participates in the regulatory pathway for exoenzyme production in *Pcc* ([@B10]; [@B58]). Therefore, we further examined the influence of the BR3 extract on the pathogenicity of *Pcc* toward Chinese cabbage. The BR3 extract significantly inhibited QS signal molecules \[*N*-acyl homoserine lactone (AHL)\] production and the virulence of *Pcc* on Chinese cabbage ([Figures 5B,C](#F5){ref-type="fig"}). Thus, the GacS/GacA system antagonist present in the BR3 extract is capable of disrupting GacS/GacA system-directed pathogenicity in phytopathogenic bacteria.

Discussion {#S4}
==========

The interaction between pathogens and plants plays a critical role in plant development and fitness, including cellular mechanisms, growth, reproduction, hormonal signaling, and tolerance to environmental stresses are involved in this process ([@B47]). Furthermore, the interactions of bacterial species in the phyllosphere influence plant development and fitness ([@B48]). It is challenging to elucidate the detailed mechanisms of the effects of the microbiota on plant function ([@B17]).

Many plant growth-promoting rhizobacteria suppress plant disease by producing one or several antibiotic compounds to inhibit the growth or directly kill the pathogens ([@B17]). However, the resistance of pathogens developed quickly under the antibiotic stress and is becoming a potential challenge for the biological control of soil-borne pathogens ([@B53]; [@B12]). Other bacterial virulence-related factors, such as two-component systems, QS systems, disulfide bond forming enzymes, and TTSSs, have been considered as attractive targets of the chemical therapy ([@B5]; [@B28]). The GacS/GacA system was one of these targets because of its global role in regulation of bacterial pathogenesis ([@B19]).

In the present study, we developed a phytopathogenic reporter bacterium *Pto* DC3000 (p970Gm-gacSDC3000p) to screen the GacS/GacA system inhibitors from extracts of rhizobacteria. Our data indicated that the extract of *Bacillus* sp. BR3 inhibited the expression of *gacS* and its downstream genes *rsmY* and *rsmZ*, and the influence of *rsmY* and *rsmZ* expression is GacA-dependent, indicating the GacS--GacA system as the potential target of the BR3 extract ([Figures 1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}). In contrast, a previous genetic study of the human opportunistic pathogen *P. aeruginosa* suggested that the antibiotic azithromycin impaired the expression of *rsmY* and *rsmZ* regardless of the function of the GacS/GacA system, because azithromycin could reduce the expression of *rsmY* and *rsmZ* in the *gacA* mutant. Azithromycin might exert its function on genetic factors other than the GacS/GacA system, which then regulate the expression of *rsmZ* ([@B21]).

Although the GacS/GacA system plays a critical role in the production of extracellular factors, ecological fitness, and even primary metabolism ([@B19]; [@B55]), the chemical signals that stimulate the GacS/GacA system remain obscure. [@B14] found that extracts from culture supernatants of *Pseudomonas* sp. and *Vibrio* sp. induced the expression of sRNAs and the production of antibiotic compounds, indicating that the signals could be self-produced. Our study further demonstrated that the BR3 extract could interfere with multiple targets of the GacS/GacA regulon in different bacterial species. In addition, overexpression of the *gacS* gene could attenuate the inhibition effect of the extract BR3 on the promoter activities of *gacS* ([Figure 1A](#F1){ref-type="fig"}). These data suggested that the BR3 extract inhibits the function of the GacS/GacA system by modulating the expression of *gacS* gene. To date, few regulatory elements have been identified to influence the expression of *gacS* ([@B20]). Our data showed that the BR3 extract could influence the GacS-dependent phenotypes in strains DC3000, 2P24, and Z3-3, whereas no conserved motif was found in the promoter regions of the *gacS* gene (data not shown), suggesting that the effect of the BR3 extract on *gacS* transcription may involve a potential regulator.

Although the method for isolation of the BR3 extract was similar to that of the AHL, the activity of the BR3 extract was not affected at pH 12 and 30°C for 1 h (data not shown). Under the same conditions, AHLs are be degraded ([@B54]). Moreover, the typical reporter system *A. tumefaciens* with the *traG*--*lacZ* fusion failed to show any reaction with the BR3 extract ([Supplementary Figure S2A](#FS2){ref-type="supplementary-material"}). These data suggested that the active ingredient from the BR3 extract does not belong to the AHL signals. Isolation of active ingredient from the BR3 extract showed that a pure compound named CX03 (MW = 413.2659) has the same inhibitory activity with the BR3 extract ([Supplementary Figures S2B,C](#FS2){ref-type="supplementary-material"}). Plant immunity is modulated by complex regulatory networks in response to abiotic and biotic factors ([@B23]). Interestingly, our data showed that HR was restricted by the BR3 extract ([Figure 3C](#F3){ref-type="fig"}). However, the BR3 extract had no effect on the transcript level of *PR1* (At2g14610) in *Arabidopsis* (data not shown). Further studies are needed to solve the chemical formula of compound CX03 and to investigate the mechanism of CX03 on plant immunity.

Rhizobacteria deploy several strategies, such as the production of antibiotics, QS, and type six secretion systems, to disrupt or otherwise manipulate commensal bacteria to facilitate their colonization and survival ([@B45]; [@B56]). Our data explored the possibility that some bacteria produce specific secondary metabolites to influence the signal transduction of others. *Bacillus* species are ubiquitous in the soil environment, and some of them are beneficial to plant growth or suppression of plant diseases ([@B48]); therefore, our findings deepen our understanding of the biocontrol mechanisms used by root-associated *Bacillus* spp.

Collectively, the extract from strain BR3 caused dysfunction of the GacS/GacA system, leading to attenuated activity of virulence factors, thus it may form the basis of a new anti-virulence strategy.
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###### 

*Bacillus* sp. BR3 antagonism assays on agar plates. Strain DC3000 **(A)**, Z3-3 **(B)**, or 2P24 **(C)** were grown in LB at 28°C overnight and mixed with LB agar (ca. 50°C) to pour into the Petri dish, respectively. Five microliters of BR3 culture (1), the extract BR3 (32 μg ml^--1^) (2), and kanamycin (50 μg ml^--1^) (3) were spotted on the plates. The plates were inoculated at 28°C for 36 h. There independent experiments were performed; a representative result is shown.

###### 

Click here for additional data file.

###### 

**(A)** The *traG*-*lacZ* fusion in *A. tumefaciens* was not induced by the BR3 extract. β-Galactosidase activities of a *traG*-*lacZ* fusion were determined in AHL reporter strain NLT4 with the BR3 extract (32 μg ml^--1^), and the 3-oxo-hexanoyl-homoserine lactone (3-oxo-C8-HSL) (3 μg ml^--1^). **(B)** Regulation of *rsmY* expression in the presence of the BR3 extract and CX03. β-Galactosidase activities of the reporter fusion *rsmY*-*lacZ* in strain DC3000 with DMSO, the BR3 extract (16 μg ml^--1^), or CX03 (2 μg ml^--1^) were measured. **(C)** Isolation of active ingredient from the BR3 extract using HPLC and LC--MS.

###### 

Click here for additional data file.
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